Results 201 to 210 of about 174,209 (261)

GLUT1 Deficiency Syndrome with Coexistent Movement Disorder and Anemia

Movement Disorders Clinical Practice, EarlyView.
Sangeetha Yoganathan, Haya S AlFaris, Anika Menetrey, Sayoni Roy Chowdhury, Lindsey Vogt, Jolynn Dickson, Karen Owusu, Pradeep Krishnan, Suvasini Sharma, Liali Aljouda, Reena Pabari, Grace Yoon, Carolina Gorodetsky   +12 more
wiley   +1 more source

Molecular characterisation of malaria and glucose-6-phosphate dehydrogenase deficiency in conflict-affected zones of central and eastern Sudan

Jebreel W, Hamid MA, Mustafa S, Awad F, Chamai M, Malpartida-Cardenas K, Amoah L, Rodriguez-Manzano J, Cunnington AJ, Mohamed A, Systems NGHRGoDDf.   +10 more
europepmc   +1 more source

Neonatal glucose-6-phosphate dehydrogenase activity by gestational age and sex: evidence-based cut-offs for newborn screening in Saudi Arabia. [PDF]

BMJ Paediatr Open
Alkaabi M, Khan AR, Al Balwi M, Al Harbi T, Ali I, Alsaif S, Ali K.   +6 more
europepmc   +1 more source

Henna-Induced Intravascular Hemolysis in a Glucose-6-Phosphate Dehydrogenase-Deficient Ghanaian Female Child with Full Defect. [PDF]

Int Med Case Rep J
Dike NO, Blankson ES, Segnitome S.
europepmc   +1 more source

Portable Point-of-Care Device for Dual Detection of Glucose-6-Phosphate Dehydrogenase Deficiency and Hemoglobin in Low-Resource Settings. [PDF]

Biosensors (Basel)
Taha RO, Youngvises N, Pochairach R, Phompradit P, Na-Bangchang K.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

GLUCOSE‐6‐PHOSPHATE DEHYDROGENASE DEFICIENCY

British Journal of Haematology, 1970
It has long been recognized that certain ordinarily salutary drugs may produce an acute hemolytic anemia in some susceptible individuals. The 8-aminoquinoline antimalarial, pamaquine (plasmoquine), was such a medication. It was the investigation of the hemolytic effect of pamaquine and its derivatives which led to the recognition that hereditary red ...
Jane F. Desforges, Ernest Beutler
openaire   +3 more sources

Glucose-6-phosphate dehydrogenase deficiency

Best Practice & Research Clinical Haematology, 2000
Glucose-6-phosphate dehydrogenase (G6PD) is expressed in all tissues, where it catalyses the first step in the pentose phosphate pathway. G6PD deficiency is prevalent throughout tropical and subtropical regions of the world because of the protection it affords during malaria infection.
A, Mehta, P J, Mason, T J, Vulliamy
openaire   +2 more sources

Glucose-6-phosphate dehydrogenase deficiency

Critical Reviews in Oncology/Hematology, 1995
Glucose-6-phosphate dehydrogenase (G6PD) is an X chromosome-linked enzyme and the key enzyme of the pentose phosphate pathway. The G6PD functions to reduce nicotinamide-adenine-dinucleotide phosphate (NADP) to a reduced form (NADPH), while it oxidizes glucosed-phosphate (G6P) in the hexose monophosphate shunt.
J G, Chang, T C, Liu
openaire   +2 more sources